United States · FDA National Drug Code directory

Otezla

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
55513-497_8d1d49ca-6dc1-4580-b2d5-f69ccb4f1c8e
Product NDC
55513-497
Form
TABLET, FILM COATED
Composition / generic term
apremilast
Labeler
Amgen, Inc
Marketing category
NDA
Marketing start / end (source format)
20240425
Source listing expiry
20271231

Source-listed ingredients

  • APREMILAST — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 TABLET, FILM COATED in 1 BOTTLE (55513-497-60) · 55513-497-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →